Transactivation of the IGF-1R by aldosterone

被引:20
|
作者
Holzman, Jennifer L.
Liu, Lian
Duke, Billie Jeanne
Kemendy, Alexandra E.
Eaton, Douglas C.
机构
[1] Emory Univ, Sch Med, Dept Physiol, Ctr Cell & Mol Signaling, Atlanta, GA 30322 USA
[2] Emory Univ, Grad Sch Arts & Sci, Grad Program Biochem Cell & Dev Biol, Atlanta, GA 30322 USA
关键词
PI3-kinase; insulin-like growth factor-1; Akt; A6; cells;
D O I
10.1152/ajprenal.00214.2006
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Activation of epithelial sodium channels (ENaC) by aldosterone, insulin, or insulin-like growth factor 1 (IGF-1) in renal epithelial cells (including the Xenopus laevis renal cell line A6) appears to share some common signaling elements subsequent to the initial insulin or IGF-1 receptor activation. Previously, the convergence point for insulin or IGF-1 and aldosterone signaling was assumed to be downstream of the receptor at the level of phosphatidylinositol 3-kinase (PI3-K); however, this study shows aldosterone directly transactivates the IGF-1 receptor (IGF-1R). In A6 cells, 10-min exposure to aldosterone increased the phosphorylation of the IGF- 1 receptor, insulin receptor substrate-1 (IRS-1), and Akt (PKB). Furthermore, aldosterone activated PI3-K and phosphorylation of the most downstream element, Akt, was blocked by the specific PI3-K inhibitor LY-294002. Transactivation requires aldosterone binding to the mineralocorticoid/glucocorticoid receptor and does not require transcription.
引用
收藏
页码:F1219 / F1228
页数:10
相关论文
共 50 条
  • [21] Expression and significance of IGF-1 and IGF-1R in thyroid nodules
    Liu, Ying-Jian
    Qiang, Wei
    Shi, Jing
    Lv, Si-Qing
    Ji, Mei-Ju
    Shi, Bing-Yin
    ENDOCRINE, 2013, 44 (01) : 158 - 164
  • [22] The mechanism of aldosterone-induced transactivation of the IGF-1 receptor
    Holzman, Jennifer L.
    Eaton, Douglas C.
    FASEB JOURNAL, 2007, 21 (05): : A544 - A544
  • [23] IGF及IGF-1R与大肠癌
    苏文利
    杨国樑
    熊斌
    辽宁医学杂志, 2000, (06) : 322 - 323
  • [24] Chronic Loop Diuretic Treatment Induces Tubular Remodeling via IGF-1R Dependent and IGF-1R Independent Signaling
    Krauson, Aram J.
    Walczak, Elisabeth M.
    Nizar, Jon M.
    Elsayed, Ragwa
    Iyer, Sonali M.
    Bhalla, Vivek
    CIRCULATION, 2017, 136
  • [25] IGF-1R and EGFR expression and IGF-1R mutational status in non-small cell lung cancer (NSCLC)
    Forde, Lydia
    Gately, Kathy
    Gray, Stephen
    Cuffe, Sinead
    Easty, David
    O'Byrne, Ken
    CANCER RESEARCH, 2010, 70
  • [26] A role for IGF-1R targeted therapy in SCLC?
    Gately, K.
    Collins, I.
    Forde, L.
    Al-Alao, A.
    O'Byrne, K. J.
    LUNG CANCER, 2010, 67 : S12 - S12
  • [27] Does Reduced IGF-1R Signaling in Igf1r+/- Mice Alter Aging?
    Bokov, Alex F.
    Garg, Neha
    Ikeno, Yuji
    Thakur, Sachin
    Musi, Nicolas
    DeFronzo, Ralph A.
    Zhang, Ning
    Erickson, Rebecca C.
    Gelfond, Jon
    Hubbard, Gene B.
    Adamo, Martin L.
    Richardson, Arlan
    PLOS ONE, 2011, 6 (11):
  • [28] Blockade of IGF-1R—not effective in neuroendocrine tumours
    Steven K. Libutti
    Nature Reviews Endocrinology, 2013, 9 : 389 - 390
  • [29] Revisiting the IGF-1R as a breast cancer target
    Roudy Chiminch Ekyalongo
    Douglas Yee
    npj Precision Oncology, 1
  • [30] Targeting the IGF-1R: the tale of the tortoise and the hare
    Crudden, Caitrin
    Girnita, Ada
    Girnita, Leonard
    FRONTIERS IN ENDOCRINOLOGY, 2015, 6